First-in-Human Implantation of a New Transcatheter Tricuspid Valve Replacement System.
Ontology highlight
ABSTRACT: Therapeutic options for patients with isolated severe to torrential tricuspid regurgitation have been limited. Because a surgical option is often not attractive, new catheter-based therapies are emerging. We report the first-in-human percutaneous transcatheter tricuspid valve replacement with the MonarQ system in a 75-year-old female patient with severely symptomatic torrential tricuspid regurgitation. (Level of Difficulty: Advanced.).
SUBMITTER: Sondergaard L
PROVIDER: S-EPMC10157149 | biostudies-literature | 2023 May
REPOSITORIES: biostudies-literature
ACCESS DATA